{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?houseId=2&min-date=2015-09-11&AnsweringBody.=Department+of+Health&min-AnswerDate=2018-01-11", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?houseId=2&min-date=2015-09-11&AnsweringBody.=Department+of+Health&min-AnswerDate=2018-01-11", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?houseId=2&min-date=2015-09-11&AnsweringBody.=Department+of+Health&min-AnswerDate=2018-01-11&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&houseId=2&min-date=2015-09-11&AnsweringBody.=Department+of+Health&min-AnswerDate=2018-01-11", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?houseId=2&min-date=2015-09-11&AnsweringBody.=Department+of+Health&min-AnswerDate=2018-01-11", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?houseId=2&min-date=2015-09-11&AnsweringBody.=Department+of+Health&min-AnswerDate=2018-01-11", "items" : [{"_about" : "http://data.parliament.uk/resources/818607", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/818607/answer", "answerText" : {"_value" : "<p>Feeling suicidal, or the risk of suicide, would not be considered to be permanent adverse reactions.<\/p><p>Mefloquine is effective in the prevention and treatment of malaria and is approved by the Medicines and Healthcare products Regulatory Agency (MHRA), which regulates medication in the United Kingdom. As with all medicines, the MHRA keeps the safety of mefloquine under continual review. Mefloquine continues to be recommended as a safe and effective form of malaria prevention by the Advisory Committee on Malaria Prevention, the World Health Organization and other respected organisations who take account of the body of global evidence.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4545", "label" : {"_value" : "Biography information for Lord O'Shaughnessy"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord O'Shaughnessy"}
        , "dateOfAnswer" : {"_value" : "2018-01-18", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2018-01-18T12:23:37.913Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2018-01-08", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Mefloquine"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government, further to the Written Answer by Lord O'Shaughnessy on 22 December 2017 (HL4314), whether they consider suicide, as listed in the current mefloquine product information as a psychiatric adverse reaction, to be a permanent adverse reaction.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1861", "label" : {"_value" : "Biography information for The Countess of Mar"}
      }
      , "tablingMemberPrinted" : [{"_value" : "The Countess of Mar"}
      ], "uin" : "HL4484"}
    , {"_about" : "http://data.parliament.uk/resources/818610", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/818610/answer", "answerText" : {"_value" : "<p>The Department does not control prices of medicines sold at pharmacies without a prescription. Emergency hormonal contraception is however available free of charge on the National Health Service.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4545", "label" : {"_value" : "Biography information for Lord O'Shaughnessy"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord O'Shaughnessy"}
        , "dateOfAnswer" : {"_value" : "2018-01-18", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2018-01-18T12:22:42.103Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2018-01-08", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Levonorgestrel: Prices"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government whether they intend to investigate the pricing of levonorgestrel by pharmacies.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3869", "label" : {"_value" : "Biography information for Lord Myners"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Myners"}
      ], "uin" : "HL4487"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}